The latest round of Medicare Advantage star ratings has created a stark divide among healthcare giants, sending Humana shares skyrocketing while leaving Alignment Healthcare in a precarious position. According to recent data from the Centers for Medicare and Medicaid Services, Humana has successfully staged one of the most dramatic recoveries in the industry. After seeing its top rated plans plummet over the last two years, the Kentucky based insurer saw the percentage of its members in four plus star plans jump from just 41 percent in 2026 to a staggering 93 percent for 2027.
This rebound is far more than a matter of prestige, as these ratings dictate massive financial incentives. Crossing the four star threshold unlocks lucrative bonuses and rebates that act as vital lifelines for insurers facing rising medical costs. Analysts suggest this turnaround could inject upwards of 3 billion dollars into Humana’s revenue by 2028, a prospect that drove investor enthusiasm and pushed the company’s stock up nearly 13 percent in post market trading following the announcement.
While Humana celebrates, Alignment Healthcare is reeling from a significant blow. The California based provider saw its primary contract slip below the critical four star mark, meaning only 25 percent of its members will now be in high rated plans compared to nearly all of them previously. This slide could cost the company over 170 million dollars in future revenue, triggering a sharp decline in its share price of more than 20 percent. In response, Alignment has signaled it may join other insurers in legal battles against the government, arguing that the federal methodology fails to accurately capture actual plan performance.
The broader trend across the sector suggests that maintaining high marks is becoming increasingly difficult. Many industry leaders including UnitedHealth and CVS experienced declines in their top tier memberships as regulators tightened scoring requirements and shifted how quality metrics are weighed. With fewer plans hitting those gold standard benchmarks overall, experts warn that these systemic drops could eventually impact senior citizens by limiting the benefits and provider choices typically associated with high performing Medicare Advantage plans.
